Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bos taurus | Trypsin II | Starlite/ChEMBL | References |
Homo sapiens | coagulation factor II (thrombin) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | Mastin | Trypsin II | 247 aa | 306 aa | 25.5 % |
Drosophila melanogaster | CG9673 gene product from transcript CG9673-RB | Trypsin II | 247 aa | 258 aa | 26.4 % |
Drosophila melanogaster | CG5909 gene product from transcript CG5909-RA | Trypsin II | 247 aa | 257 aa | 28.8 % |
Drosophila melanogaster | CG9733 gene product from transcript CG9733-RB | Trypsin II | 247 aa | 262 aa | 31.3 % |
Drosophila melanogaster | Spatzle-Processing Enzyme | Trypsin II | 247 aa | 269 aa | 27.5 % |
Schistosoma mansoni | cercarial elastase (S01 family) | Trypsin II | 247 aa | 217 aa | 23.0 % |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | Trypsin II | 247 aa | 247 aa | 34.0 % |
Drosophila melanogaster | Jonah 66Ci | Trypsin II | 247 aa | 237 aa | 30.4 % |
Drosophila melanogaster | Jonah 65Aiii | Trypsin II | 247 aa | 238 aa | 32.8 % |
Drosophila melanogaster | CG4815 gene product from transcript CG4815-RA | Trypsin II | 247 aa | 208 aa | 27.4 % |
Drosophila melanogaster | CG4914 gene product from transcript CG4914-RA | Trypsin II | 247 aa | 244 aa | 37.3 % |
Echinococcus granulosus | subfamily S1A unassigned peptidase S01 family | Trypsin II | 247 aa | 287 aa | 27.2 % |
Drosophila melanogaster | CG3505 gene product from transcript CG3505-RA | Trypsin II | 247 aa | 236 aa | 30.1 % |
Echinococcus granulosus | transmembrane protease serine 3 | Trypsin II | 247 aa | 233 aa | 34.3 % |
Onchocerca volvulus | Trypsin II | 247 aa | 257 aa | 26.5 % | |
Schistosoma japonicum | ko:K09637 transmembrane protease, serine 6, putative | Trypsin II | 247 aa | 242 aa | 29.8 % |
Drosophila melanogaster | CG10405 gene product from transcript CG10405-RB | Trypsin II | 247 aa | 254 aa | 33.1 % |
Echinococcus multilocularis | transmembrane protease serine 3 | Trypsin II | 247 aa | 233 aa | 34.8 % |
Drosophila melanogaster | CG13744 gene product from transcript CG13744-RA | Trypsin II | 247 aa | 250 aa | 31.6 % |
Drosophila melanogaster | CG18180 gene product from transcript CG18180-RA | Trypsin II | 247 aa | 234 aa | 31.2 % |
Echinococcus granulosus | enteropeptidase | Trypsin II | 247 aa | 227 aa | 26.4 % |
Drosophila melanogaster | CG32277 gene product from transcript CG32277-RA | Trypsin II | 247 aa | 240 aa | 32.9 % |
Drosophila melanogaster | CG31326 gene product from transcript CG31326-RA | Trypsin II | 247 aa | 249 aa | 23.7 % |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | Trypsin II | 247 aa | 302 aa | 25.5 % |
Echinococcus granulosus | glycoprotein Antigen 5 | Trypsin II | 247 aa | 301 aa | 22.3 % |
Schistosoma japonicum | Enteropeptidase, putative | Trypsin II | 247 aa | 267 aa | 26.2 % |
Onchocerca volvulus | Trypsin II | 247 aa | 258 aa | 22.9 % | |
Drosophila melanogaster | CG31267 gene product from transcript CG31267-RA | Trypsin II | 247 aa | 263 aa | 32.7 % |
Drosophila melanogaster | CG34436 gene product from transcript CG34436-RA | Trypsin II | 247 aa | 213 aa | 24.9 % |
Schistosoma mansoni | cercarial elastase (S01 family) | Trypsin II | 247 aa | 239 aa | 22.2 % |
Schistosoma japonicum | Transmembrane protease, serine 9, putative | Trypsin II | 247 aa | 246 aa | 24.8 % |
Drosophila melanogaster | CG11313 gene product from transcript CG11313-RC | Trypsin II | 247 aa | 223 aa | 33.2 % |
Drosophila melanogaster | CG31220 gene product from transcript CG31220-RB | Trypsin II | 247 aa | 224 aa | 29.5 % |
Drosophila melanogaster | CG30323 gene product from transcript CG30323-RB | Trypsin II | 247 aa | 212 aa | 23.6 % |
Echinococcus multilocularis | subfamily S1A unassigned peptidase (S01 family) | Trypsin II | 247 aa | 287 aa | 27.2 % |
Schistosoma mansoni | cercarial elastase (S01 family) | Trypsin II | 247 aa | 217 aa | 23.0 % |
Drosophila melanogaster | CG30083 gene product from transcript CG30083-RB | Trypsin II | 247 aa | 205 aa | 30.2 % |
Echinococcus multilocularis | glycoprotein Antigen 5 | Trypsin II | 247 aa | 302 aa | 23.2 % |
Drosophila melanogaster | Jonah 99Ci | Trypsin II | 247 aa | 268 aa | 32.5 % |
Drosophila melanogaster | Jonah 65Aii | Trypsin II | 247 aa | 237 aa | 35.4 % |
Drosophila melanogaster | CG3916 gene product from transcript CG3916-RA | Trypsin II | 247 aa | 257 aa | 33.5 % |
Drosophila melanogaster | CG30288 gene product from transcript CG30288-RC | Trypsin II | 247 aa | 248 aa | 28.6 % |
Drosophila melanogaster | CG14990 gene product from transcript CG14990-RA | Trypsin II | 247 aa | 238 aa | 30.2 % |
Schistosoma japonicum | ko:K01346 pancreatic elastase II [EC3.4.21.71], putative | Trypsin II | 247 aa | 303 aa | 24.8 % |
Drosophila melanogaster | CG33458 gene product from transcript CG33458-RA | Trypsin II | 247 aa | 255 aa | 29.4 % |
Echinococcus granulosus | Mastin | Trypsin II | 247 aa | 306 aa | 25.2 % |
Drosophila melanogaster | CG30287 gene product from transcript CG30287-RA | Trypsin II | 247 aa | 251 aa | 27.1 % |
Drosophila melanogaster | CG17239 gene product from transcript CG17239-RB | Trypsin II | 247 aa | 224 aa | 34.4 % |
Schistosoma mansoni | aminopeptidase PILS (M01 family) | Trypsin II | 247 aa | 298 aa | 24.5 % |
Echinococcus multilocularis | enteropeptidase | Trypsin II | 247 aa | 227 aa | 26.0 % |
Drosophila melanogaster | CG33465 gene product from transcript CG33465-RC | Trypsin II | 247 aa | 203 aa | 20.7 % |
Drosophila melanogaster | CG18420 gene product from transcript CG18420-RA | Trypsin II | 247 aa | 233 aa | 28.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | MBOAT family protein | 0.054 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0117 | 0.0889 | 0.0889 |
Onchocerca volvulus | 0.0117 | 0.0889 | 1 | |
Echinococcus granulosus | protein cysteine N palmitoyltransferase | 0.054 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.0889 | 0.0889 |
Echinococcus granulosus | zinc finger protein | 0.0493 | 0.8998 | 0.8998 |
Schistosoma mansoni | zinc finger protein | 0.054 | 1 | 1 |
Onchocerca volvulus | 0.0106 | 0.0665 | 0.7483 | |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0117 | 0.0889 | 0.0889 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.0889 | 0.0889 |
Echinococcus multilocularis | zinc finger protein | 0.0493 | 0.8998 | 0.8998 |
Brugia malayi | Trypsin family protein | 0.0117 | 0.0889 | 0.0889 |
Echinococcus multilocularis | protein cysteine N palmitoyltransferase | 0.054 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
2x APTT (functional) | = 22.6 uM | Concentration required to double the activated partial thromboplastin time in human plasma | ChEMBL. | 15149685 |
Ki (binding) | = 0.022 uM | In vitro inhibition of human thrombin. | ChEMBL. | 15149685 |
Ki (binding) | = 0.022 uM | In vitro inhibition of human thrombin. | ChEMBL. | 15149685 |
Ki (binding) | = 8.06 uM | In vitro inhibition of bovine trypsin. | ChEMBL. | 15149685 |
Ki (binding) | = 8.06 uM | In vitro inhibition of bovine trypsin. | ChEMBL. | 15149685 |
Ki (binding) | = 131 uM | In vitro inhibition of Coagulation factor Xa. | ChEMBL. | 15149685 |
Ki (binding) | = 131 uM | In vitro inhibition of Coagulation factor Xa. | ChEMBL. | 15149685 |
pKa | = 3.17 | Dissociation constant of the compound was evaluated | ChEMBL. | 15149685 |
PT (functional) | 0 uM | Concentration required to double the prothrombin time in human plasma; ND=Not determined | ChEMBL. | 15149685 |
Selectivity (binding) | = 201 | Selectivity for inhibition of thrombin over trypsin. | ChEMBL. | 15149685 |
TT (functional) | 0 uM | Concentration of inhibitor to double the thrombin time in human plasma; ND=Not determined | ChEMBL. | 15149685 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.